ID   CMC2_HUMAN              Reviewed;         675 AA.
AC   Q9UJS0; O14566; O14575; Q546F9; Q9NZW1; Q9UNI7;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   21-FEB-2001, sequence version 2.
DT   10-MAY-2017, entry version 174.
DE   RecName: Full=Calcium-binding mitochondrial carrier protein Aralar2;
DE   AltName: Full=Citrin;
DE   AltName: Full=Mitochondrial aspartate glutamate carrier 2;
DE   AltName: Full=Solute carrier family 25 member 13;
GN   Name=SLC25A13; Synonyms=ARALAR2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), INVOLVEMENT IN
RP   CTLN2, AND TISSUE SPECIFICITY.
RX   PubMed=10369257; DOI=10.1038/9667;
RA   Kobayashi K., Sinasac D.S., Iijima M., Boright A.P., Begum L.,
RA   Lee J.R., Yasuda T., Ikeda S., Hirano R., Terazono H., Crackower M.A.,
RA   Kondo I., Tsui L.-C., Scherer S.W., Saheki T.;
RT   "The gene mutated in adult-onset type II citrullinaemia encodes a
RT   putative mitochondrial carrier protein.";
RL   Nat. Genet. 22:159-163(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY,
RP   SUBCELLULAR LOCATION, AND CALCIUM-BINDING.
RC   TISSUE=Liver;
RX   PubMed=10642534; DOI=10.1042/0264-6021:3450725;
RA   Del Arco A., Agudo M., Satrustegui J.;
RT   "Characterization of a second member of the subfamily of calcium-
RT   binding mitochondrial carriers expressed in human non-excitable
RT   tissues.";
RL   Biochem. J. 345:725-732(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND FUNCTION.
RX   PubMed=11566871; DOI=10.1093/emboj/20.18.5060;
RA   Palmieri L., Pardo B., Lasorsa F.M., del Arco A., Kobayashi K.,
RA   Iijima M., Runswick M.J., Walker J.E., Saheki T., Satrustegui J.,
RA   Palmieri F.;
RT   "Citrin and aralar1 are Ca(2+)-stimulated aspartate/glutamate
RT   transporters in mitochondria.";
RL   EMBO J. 20:5060-5069(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 6-251, AND INVOLVEMENT IN CTLN2.
RX   PubMed=10610724; DOI=10.1006/geno.1999.6006;
RA   Sinasac D.S., Crackower M.A., Lee J.R., Kobayashi K., Saheki T.,
RA   Scherer S.W., Tsui L.-C.;
RT   "Genomic structure of the adult-onset type II citrullinemia gene,
RT   SLC25A13, and cloning and expression of its mouse homologue.";
RL   Genomics 62:289-292(1999).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-666, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT LYS-453, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [14]
RP   VARIANT NICCD LYS-601.
RX   PubMed=11793471; DOI=10.1002/humu.10022;
RA   Yamaguchi N., Kobayashi K., Yasuda T., Nishi I., Iijima M.,
RA   Nakagawa M., Osame M., Kondo I., Saheki T.;
RT   "Screening of SLC25A13 mutations in early and late onset patients with
RT   citrin deficiency and in the Japanese population: identification of
RT   two novel mutations and establishment of multiple DNA diagnosis
RT   methods for nine mutations.";
RL   Hum. Mutat. 19:122-130(2002).
CC   -!- FUNCTION: Catalyzes the calcium-dependent exchange of cytoplasmic
CC       glutamate with mitochondrial aspartate across the mitochondrial
CC       inner membrane. May have a function in the urea cycle.
CC       {ECO:0000269|PubMed:11566871}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000269|PubMed:10642534}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:10642534}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UJS0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UJS0-2; Sequence=VSP_043747;
CC   -!- TISSUE SPECIFICITY: High levels in liver and low levels in kidney,
CC       pancreas, placenta, heart and brain. {ECO:0000269|PubMed:10369257,
CC       ECO:0000269|PubMed:10642534}.
CC   -!- DISEASE: Citrullinemia 2 (CTLN2) [MIM:603471]: A form of
CC       citrullinemia, an autosomal recessive disease characterized
CC       primarily by elevated serum and urine citrulline levels. Ammonia
CC       intoxication is another manifestation. Citrullinemia type 2 is
CC       characterized by neuropsychiatric symptoms including abnormal
CC       behaviors, loss of memory, seizures and coma. Death can result
CC       from brain edema. Onset is sudden and usually between the ages of
CC       20 and 50 years. {ECO:0000269|PubMed:10369257,
CC       ECO:0000269|PubMed:10610724}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Cholestasis, neonatal intrahepatic, caused by citrin
CC       deficiency (NICCD) [MIM:605814]: A form of citrullinemia type 2
CC       with neonatal onset, characterized by suppression of the bile
CC       flow, hepatic fibrosis, low birth weight, growth retardation,
CC       hypoproteinemia, variable liver dysfunction. Neonatal intrahepatic
CC       cholestasis due to citrin deficiency is generally not severe and
CC       symptoms disappear by one year of age with an appropriate diet.
CC       Years or even decades later, however, some individuals develop the
CC       characteristic features of citrullinemia type 2 with
CC       neuropsychiatric symptoms. {ECO:0000269|PubMed:11793471}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- MISCELLANEOUS: Binds calcium.
CC   -!- SIMILARITY: Belongs to the mitochondrial carrier (TC 2.A.29)
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB67049.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=AAB70112.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF118838; AAD38501.1; -; mRNA.
DR   EMBL; Y17571; CAB62206.1; -; mRNA.
DR   EMBL; AJ496569; CAD43091.1; -; mRNA.
DR   EMBL; AC002540; AAB70112.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AC002450; AAB67049.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AC004458; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC084368; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC096775; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471091; EAW76748.1; -; Genomic_DNA.
DR   EMBL; BC006566; AAH06566.1; -; mRNA.
DR   EMBL; AH009104; AAF28473.1; -; Genomic_DNA.
DR   CCDS; CCDS55130.1; -. [Q9UJS0-2]
DR   CCDS; CCDS5645.1; -. [Q9UJS0-1]
DR   RefSeq; NP_001153682.1; NM_001160210.1. [Q9UJS0-2]
DR   RefSeq; NP_055066.1; NM_014251.2. [Q9UJS0-1]
DR   UniGene; Hs.489190; -.
DR   PDB; 4P5W; X-ray; 2.40 A; A/B=2-319, A/B=612-675.
DR   PDBsum; 4P5W; -.
DR   ProteinModelPortal; Q9UJS0; -.
DR   SMR; Q9UJS0; -.
DR   BioGrid; 115467; 44.
DR   IntAct; Q9UJS0; 49.
DR   MINT; MINT-3081120; -.
DR   STRING; 9606.ENSP00000400101; -.
DR   DrugBank; DB00128; L-Aspartic Acid.
DR   TCDB; 2.A.29.14.2; the mitochondrial carrier (mc) family.
DR   iPTMnet; Q9UJS0; -.
DR   PhosphoSitePlus; Q9UJS0; -.
DR   SwissPalm; Q9UJS0; -.
DR   BioMuta; SLC25A13; -.
DR   DMDM; 13124095; -.
DR   EPD; Q9UJS0; -.
DR   PaxDb; Q9UJS0; -.
DR   PeptideAtlas; Q9UJS0; -.
DR   PRIDE; Q9UJS0; -.
DR   DNASU; 10165; -.
DR   Ensembl; ENST00000265631; ENSP00000265631; ENSG00000004864. [Q9UJS0-1]
DR   Ensembl; ENST00000416240; ENSP00000400101; ENSG00000004864. [Q9UJS0-2]
DR   GeneID; 10165; -.
DR   KEGG; hsa:10165; -.
DR   UCSC; uc003uof.5; human. [Q9UJS0-1]
DR   CTD; 10165; -.
DR   DisGeNET; 10165; -.
DR   GeneCards; SLC25A13; -.
DR   GeneReviews; SLC25A13; -.
DR   H-InvDB; HIX0167840; -.
DR   HGNC; HGNC:10983; SLC25A13.
DR   HPA; HPA018997; -.
DR   MalaCards; SLC25A13; -.
DR   MIM; 603471; phenotype.
DR   MIM; 603859; gene.
DR   MIM; 605814; phenotype.
DR   neXtProt; NX_Q9UJS0; -.
DR   OpenTargets; ENSG00000004864; -.
DR   Orphanet; 247585; Citrullinemia type II.
DR   Orphanet; 247598; Neonatal intrahepatic cholestasis due to citrin deficiency.
DR   PharmGKB; PA35859; -.
DR   eggNOG; KOG0751; Eukaryota.
DR   eggNOG; ENOG410XNRM; LUCA.
DR   GeneTree; ENSGT00530000062944; -.
DR   HOGENOM; HOG000180633; -.
DR   HOVERGEN; HBG005350; -.
DR   InParanoid; Q9UJS0; -.
DR   KO; K15105; -.
DR   OMA; CDEFEAV; -.
DR   OrthoDB; EOG091G08GT; -.
DR   PhylomeDB; Q9UJS0; -.
DR   TreeFam; TF313209; -.
DR   Reactome; R-HSA-1268020; Mitochondrial protein import.
DR   Reactome; R-HSA-70263; Gluconeogenesis.
DR   ChiTaRS; SLC25A13; human.
DR   GenomeRNAi; 10165; -.
DR   PRO; PR:Q9UJS0; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000004864; -.
DR   CleanEx; HS_SLC25A13; -.
DR   ExpressionAtlas; Q9UJS0; baseline and differential.
DR   Genevisible; Q9UJS0; HS.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; NAS:UniProtKB.
DR   GO; GO:0005743; C:mitochondrial inner membrane; ISS:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0015172; F:acidic amino acid transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0015183; F:L-aspartate transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0005313; F:L-glutamate transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0005215; F:transporter activity; NAS:UniProtKB.
DR   GO; GO:0015810; P:aspartate transport; IDA:UniProtKB.
DR   GO; GO:0006754; P:ATP biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0045333; P:cellular respiration; IDA:UniProtKB.
DR   GO; GO:0006094; P:gluconeogenesis; TAS:Reactome.
DR   GO; GO:0015813; P:L-glutamate transport; IDA:UniProtKB.
DR   GO; GO:0043490; P:malate-aspartate shuttle; IDA:UniProtKB.
DR   GO; GO:0051592; P:response to calcium ion; IDA:UniProtKB.
DR   GO; GO:0006810; P:transport; NAS:UniProtKB.
DR   Gene3D; 1.50.40.10; -; 1.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR002067; Mit_carrier.
DR   InterPro; IPR018108; Mitochondrial_sb/sol_carrier.
DR   InterPro; IPR023395; Mt_carrier_dom.
DR   Pfam; PF00153; Mito_carr; 3.
DR   PRINTS; PR00926; MITOCARRIER.
DR   SUPFAM; SSF103506; SSF103506; 1.
DR   SUPFAM; SSF47473; SSF47473; 2.
DR   PROSITE; PS50222; EF_HAND_2; 2.
DR   PROSITE; PS50920; SOLCAR; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Calcium;
KW   Complete proteome; Disease mutation; Intrahepatic cholestasis;
KW   Membrane; Metal-binding; Methylation; Mitochondrion;
KW   Mitochondrion inner membrane; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Transmembrane; Transmembrane helix;
KW   Transport.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22814378,
FT                                ECO:0000244|PubMed:25944712}.
FT   CHAIN         2    675       Calcium-binding mitochondrial carrier
FT                                protein Aralar2.
FT                                /FTId=PRO_0000090600.
FT   TRANSMEM    332    349       Helical; Name=1. {ECO:0000255}.
FT   TRANSMEM    393    412       Helical; Name=2. {ECO:0000255}.
FT   TRANSMEM    436    449       Helical; Name=3. {ECO:0000255}.
FT   TRANSMEM    485    504       Helical; Name=4. {ECO:0000255}.
FT   TRANSMEM    524    541       Helical; Name=5. {ECO:0000255}.
FT   TRANSMEM    581    600       Helical; Name=6. {ECO:0000255}.
FT   DOMAIN       51     86       EF-hand 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN       87    122       EF-hand 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      125    157       EF-hand 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      158    193       EF-hand 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   REPEAT      326    418       Solcar 1.
FT   REPEAT      426    510       Solcar 2.
FT   REPEAT      518    606       Solcar 3.
FT   CA_BIND      66     77       1.
FT   CA_BIND     100    111       2.
FT   CA_BIND     171    182       3.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22814378,
FT                                ECO:0000244|PubMed:25944712}.
FT   MOD_RES     353    353       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9QXX4}.
FT   MOD_RES     372    372       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9QXX4}.
FT   MOD_RES     453    453       N6-methyllysine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     484    484       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9QXX4}.
FT   MOD_RES     484    484       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9QXX4}.
FT   MOD_RES     580    580       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9QXX4}.
FT   MOD_RES     662    662       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9QXX4}.
FT   MOD_RES     666    666       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     311    311       Q -> QQ (in isoform 2).
FT                                {ECO:0000303|PubMed:11566871}.
FT                                /FTId=VSP_043747.
FT   VARIANT     141    141       E -> K (in dbSNP:rs1131697).
FT                                /FTId=VAR_050126.
FT   VARIANT     232    232       L -> I (in dbSNP:rs10255762).
FT                                /FTId=VAR_050127.
FT   VARIANT     601    601       E -> K (in NICCD; dbSNP:rs80338727).
FT                                {ECO:0000269|PubMed:11793471}.
FT                                /FTId=VAR_016601.
FT   CONFLICT    231    232       EL -> VH (in Ref. 2; CAB62206).
FT                                {ECO:0000305}.
FT   CONFLICT    532    532       M -> T (in Ref. 2; CAB62206).
FT                                {ECO:0000305}.
FT   HELIX        14     24       {ECO:0000244|PDB:4P5W}.
FT   STRAND       27     29       {ECO:0000244|PDB:4P5W}.
FT   STRAND       32     35       {ECO:0000244|PDB:4P5W}.
FT   HELIX        37     40       {ECO:0000244|PDB:4P5W}.
FT   TURN         41     44       {ECO:0000244|PDB:4P5W}.
FT   HELIX        55     65       {ECO:0000244|PDB:4P5W}.
FT   STRAND       70     73       {ECO:0000244|PDB:4P5W}.
FT   HELIX        75     86       {ECO:0000244|PDB:4P5W}.
FT   HELIX        90     99       {ECO:0000244|PDB:4P5W}.
FT   HELIX       109    118       {ECO:0000244|PDB:4P5W}.
FT   HELIX       120    124       {ECO:0000244|PDB:4P5W}.
FT   HELIX       132    138       {ECO:0000244|PDB:4P5W}.
FT   TURN        139    142       {ECO:0000244|PDB:4P5W}.
FT   HELIX       148    170       {ECO:0000244|PDB:4P5W}.
FT   STRAND      175    179       {ECO:0000244|PDB:4P5W}.
FT   HELIX       180    190       {ECO:0000244|PDB:4P5W}.
FT   HELIX       192    194       {ECO:0000244|PDB:4P5W}.
FT   HELIX       197    208       {ECO:0000244|PDB:4P5W}.
FT   STRAND      213    216       {ECO:0000244|PDB:4P5W}.
FT   HELIX       217    228       {ECO:0000244|PDB:4P5W}.
FT   HELIX       230    241       {ECO:0000244|PDB:4P5W}.
FT   HELIX       251    258       {ECO:0000244|PDB:4P5W}.
FT   HELIX       266    279       {ECO:0000244|PDB:4P5W}.
FT   STRAND      283    285       {ECO:0000244|PDB:4P5W}.
FT   HELIX       287    293       {ECO:0000244|PDB:4P5W}.
FT   HELIX       638    642       {ECO:0000244|PDB:4P5W}.
FT   HELIX       643    654       {ECO:0000244|PDB:4P5W}.
SQ   SEQUENCE   675 AA;  74176 MW;  AD07EDBC6C68989B CRC64;
     MAAAKVALTK RADPAELRTI FLKYASIEKN GEFFMSPNDF VTRYLNIFGE SQPNPKTVEL
     LSGVVDQTKD GLISFQEFVA FESVLCAPDA LFMVAFQLFD KAGKGEVTFE DVKQVFGQTT
     IHQHIPFNWD SEFVQLHFGK ERKRHLTYAE FTQFLLEIQL EHAKQAFVQR DNARTGRVTA
     IDFRDIMVTI RPHVLTPFVE ECLVAAAGGT TSHQVSFSYF NGFNSLLNNM ELIRKIYSTL
     AGTRKDVEVT KEEFVLAAQK FGQVTPMEVD ILFQLADLYE PRGRMTLADI ERIAPLEEGT
     LPFNLAEAQR QKASGDSARP VLLQVAESAY RFGLGSVAGA VGATAVYPID LVKTRMQNQR
     STGSFVGELM YKNSFDCFKK VLRYEGFFGL YRGLLPQLLG VAPEKAIKLT VNDFVRDKFM
     HKDGSVPLAA EILAGGCAGG SQVIFTNPLE IVKIRLQVAG EITTGPRVSA LSVVRDLGFF
     GIYKGAKACF LRDIPFSAIY FPCYAHVKAS FANEDGQVSP GSLLLAGAIA GMPAASLVTP
     ADVIKTRLQV AARAGQTTYS GVIDCFRKIL REEGPKALWK GAGARVFRSS PQFGVTLLTY
     ELLQRWFYID FGGVKPMGSE PVPKSRINLP APNPDHVGGY KLAVATFAGI ENKFGLYLPL
     FKPSVSTSKA IGGGP
//
